EMJ GOLD

Why is the purpose and value of medical affairs sometimes poorly understood by the wider pharma organisation, and what can be done?

In his second column, Davidek Herron, Global Head of Digital, Roche, considers this year’s successes and challenges and looks ahead to 2023.

While technology advances and mindsets shift, will there be space and demand for the role of the pharma sales reps in future?

The Japanese pharma industry has many intricacies, so how can companies navigate the ups and downs?

Daiichi Sankyo’s Mary Pinder-Schenck speaks about the evolution she has witnessed in oncology throughout her career and what she predicts for the future of the field.

A new review has outlined 20 recommendations for how the UK can become a world leader in cannabinoid innovation. But is it possible?

The pharmaceutical industry has been trying to refine, reduce and replace animal testing for some time, but animal rights activists argue progress is too incremental.

The overturning of Roe v. Wade is impacting access to medical abortion, but in what ways is pharma trying to help?

Two US pricing experts dissect the implications of The Inflation Reduction for the pharma industry in this roundtable.

Landmark science has led to an inundation of new transformative therapies, but is the cell and gene market at the point of saturation?

What techniques can pharma companies adopt and adapt from the tech giants dominating the stage of modern-day innovation?

What drives Novartis Oncology’s Reshema Kemps-Polanco to succeed?

Five minutes with Anat Cohen-Dayag, CEO of clinical-stage drug discovery and development company Compugen.

After dizzying heights of investment during the pandemic, biotechs have observed a slump, but the future may look more promising.

AI is being implemented into drug development to free up time, money and manpower, but how can humans and computers work together?

In his first regular column for GOLD, Davidek Herron discusses digital transformation in pharma and pursuing operational excellence.

With opioid abuse showing little sign of abating, what role can pharma play in addressing the crisis?

Kenya is home to a budding pharma sector, but the country still faces access to medicine challenges. What are they, and how can pharma help?

Hear from two industry thought leaders to find out how the pharmaceutical industry is harnessing the COVID-19 to advance rather than derail their mission to improve female representation.

Clinical trials of the past struggled with patient enrolment and cost efficiency. What can the pharmaceutical industry learn to improve them?

In this roundtable, hear from two industry thought leaders who share their ideas on how to build synergy between pharma and patients.

What is it like to switch from medicine to MA, and are we about to see this spike in the wake of COVID-19?

With continued drive for equality across the pharma industry, the issue of parental leave is coming to the fore. But is the industry’s approach sufficiently transparent, and what more can be done?

How can pharma embrace post-conference momentum?

What is a digital twin and how do they benefit pharma?

How can pharma boost R&D efforts into women’s health issues?

Decentralised clinical trials are held in high regard in terms of climate impact, but are they as sustainable as they seem?

How can pharma tackle public mistrust in genomic medicine?

The pharmaceutical industry is a rich source of material for the small screen, but why is it framed as the perpetual bad boy?

How does a physician make a difference in medical affairs? Juby Jacob-Nara tells her story.

What lies in wait for pharma in the social media jungle?

Blockchain allow patients to own their data and better protects their personal information. How could it change the data landscape in pharma?

India, known by some as ‘the pharmacy of the world’, has a growing pharma reputation, but what has shaped this company’s ascension to pharmaceutical powerhouse status?

How can the industry empower MSLs as they do sales reps?

The Sunshine Rule swept away the clouds that cast shade over the pharmaceutical industry’s interactions with its customers, but what has been its impact five years on?

Sanofi’s Bill Sibold shares his tips on reducing time to market for pharmaceutical drugs, public perceptions of the industry after COVID-19 and more.

Are public-private partnerships set to be drivers of innovation across the pharmaceutical industry? Read to find out more.

Non-adherence to medication can be caused by a range of factors, including unconscious biases. How can pharma rework current models to ensure they are connecting with patients?

Read the article to find out what action the pharma industry has taken to help Ukraine during the conflict.

Antimicrobial resistance poses a significant threat to human health worldwide, with inconceivable consequences. Is pharma doing enough?

Claus Zieler, President of Established Markets at Astellas, speaks about the role leaders play in cultivating an enticing company culture

Brazil has consistently appeared in the top 10 global pharmaceutical markets over the last decade and is making steady progress.

The first-time launch landscape is growing. In an increasing number of cases, it’s emerging biopharma and biotech companies launching new drugs rather than established pharma giants leading the way.

Reverse mentoring challenges the status quo and flips traditional learning dynamics on their axis. This how-to guide deconstructs what must be considered when building a reverse mentoring scheme in pharma.

How can emergency measures be translated into permanent solutions to increase the power and number of these trials?

A highly-effective pharmacovigilance function is a rising value differentiator for pharmaceutical companies. Read to find out more about the challenges.

The pharmaceutical industry views itself as increasingly patient centric, but do two patient advocates agree? In this roundtable discussion, they consider what the industry is doing well, and their views on how it could improve further

John Wahba, Medical Head of the Global Digital Hub, GSK, talks about how collaboration and teamwork will drive change in pharma, his views on digital and omnichannel optimisation and his passion for patient empowerment

The ambition of the Healthcare Businesswomen’s Association is to drive change in diversity, equity and inclusion healthcare and life sciences. Read the article to find out how.

TikTok took younger generations by storm in 2021. Is it time for pharma to turn to the platform? Read the article to find out more.

While the pharma industry is far away from immersing patients and HCPs in an open world of role play games, extended use of gamification is certainly on the horizon. FInd out more.

Exploring the pharmaceutical landscape in South Africa, GOLD considers several areas that are shaping the nation’s role in the future of global pharmaceuticals

GOLD explores pharma’s future in the metaverse, untangling the good, the bad and the uncertainties. Find out more.

Davidek Herron, Global Head of Digital at Roche, speaks to Isabel O’Brien about the myths surrounding digital transformation and much more.

The FDA has released new guidance on the use of real-world data and real-world evidence in drug development.

GOLD reviews the pharma industry approach to organisational change, strategising tips to drive it from the top down or bottom up.

The pharmaceutical industry needs to help restoring pre-pandemic routine vaccination levels and protect populations worldwide.

Today is World Health Day, and to celebrate GOLD asked Claire Gillis, CEO, VMLY&R Health, to share her thoughts on using creativity to create better access to healthcare for all

Now that the world has had time to see the risks and rewards of ChatGPT, pharma industry must decide whether to take it or leave it. Read for more.

Digital therapeutics are making their way onto the main stage, and pharma should be taking note. What lies ahead for potential partnerships?

GOLD explores what the pharmaceutical industry’s future might look like with the adoption of blockchain technology within its key functions.

Technology has redefined the exchange of health information. Find out how the pharma industry can help patients build confidence about digital health tools.

Europe is a front runner for pharmaceutical research and thought leadership Find out in what measure this is translating into home-grown innovation.

The pharmaceutical supply chain is vulnerable to adverse events, and the pandemic has served as a reminder of how these networks can be tested. The industry has learned tough lessons from COVID-19 that must be translated into modernisation and improvements